| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Oct 2025 | 23 Sep 2025 |
| Navin Fluorine International Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2025 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday October 30 2025 inter-alia to consider approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ending September 30 2025; and to consider declaration of interim dividend for the financial year 2025-2026. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 read with the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and their Immediate Relatives the Trading Window in respect of dealings in the securities of the Company will remain closed from September 30 2025 to November 01 2025 (both days inclusive). This intimation is also being made available on the Companys website www.nfil.in. Outcome of Board Meeting held on October 30, 2025 (As per BSE Announcement dated on: 30.10.2025) | ||
| Board Meeting | 30 Jul 2025 | 25 Jun 2025 |
| Navin Fluorine International Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ending June 30 2025. Outcome of Board Meeting held on July 30, 2025 (As Per BSE Announcement Dated on: 30.07.2025) | ||
| Board Meeting | 7 Jul 2025 | 7 Jul 2025 |
| Qualified institutions placement of such number of equity shares of face value ?2 each (the Equity Shares) by Navin Fluorine International Limited (the Company) aggregating to an amount of up to ? 750 crore, under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the SEBI ICDR Regulations), and Sections 42, 23(1)(b) and 62(1)(c) of the Companies Act, 2013, including the rules made thereunder, each as amended (the Issue). | ||
| Board Meeting | 9 May 2025 | 25 Mar 2025 |
| Navin Fluorine International Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve and take on record the Annual Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ending March 31 2025; and to consider and recommend final dividend for the Financial Year 2024-2025. Outcome of Board Meeting held on May 09, 2025 The Board of Directors has recommended final dividend of ?7/- per equity share of the face value of ?2/- each (i.e. 350% of the face value) for the financial year 2024-2025 subject to approval of the Members of the Company at the forthcoming 27 th Annual General Meeting to be held on July 31, 2025. (As Per BSE Announcement Dated on 09.05.2025) | ||
| Board Meeting | 6 May 2025 | 7 May 2025 |
| The Board of Directors of the Company have at their Meeting held on May 06, 2025 approved Capital Expenditure arrangement of approx. Rs. 120 crores. The requisite details of the same are enclosed. The Joint Press release from the Company and the Customer is attached herewith. The Meeting of the Board of Directors commenced at 10.30 PM (IST) and ended at 11.35 PM (IST) | ||
| Board Meeting | 30 Jan 2025 | 23 Dec 2024 |
| Navin Fluorine International Limited-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ending December 31 2024 Outcome of Board Meeting held January 30, 2025 Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024 (As per BSE Announcement Dated on 30/01/2025) | ||
Revenue from operations rose year-on-year by 16.45% at ₹701 crore from ₹602 crore in Q4 FY24.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
